المؤلفون: Murakami M; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Fujimori N; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Takamatsu Y; Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, Fukuoka, Japan., Ito T; Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, Fukuoka, Japan.; Department of Gastroenterology, Graduate School of Medical Sciences, International University of Health and Welfare, Fukuoka, Japan., Matsumoto K; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Kakehashi S; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Ohno A; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Teramatsu K; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Ueda K; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Ishigami K; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Ogawa Y; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Jun 01; Vol. 54 (6), pp. 647-657.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Neuroendocrine Tumors*/drug therapy , Neuroendocrine Tumors*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Intestinal Neoplasms*/drug therapy , Intestinal Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Japan ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Treatment Outcome ; East Asian People

SCR Disease Name: Gastro-enteropancreatic neuroendocrine tumor

المؤلفون: Webster AP; Department of Clinical and Biomedical Science, University of Exeter College of Medicine and Health, Exeter, EX2 5DW, UK., Thirlwell C; Department of Clinical and Biomedical Science, University of Exeter College of Medicine and Health, Exeter, EX2 5DW, UK.; University of Bristol Medical School, University of Bristol, Bristol, BS8 1UD, UK.

المصدر: Endocrine reviews [Endocr Rev] 2024 May 07; Vol. 45 (3), pp. 343-350.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8006258 Publication Model: Print Cited Medium: Internet ISSN: 1945-7189 (Electronic) Linking ISSN: 0163769X NLM ISO Abbreviation: Endocr Rev Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/genetics , Neuroendocrine Tumors*/metabolism , Intestinal Neoplasms*/genetics , Intestinal Neoplasms*/metabolism , Intestinal Neoplasms*/pathology, Humans ; Animals ; Epigenesis, Genetic

المؤلفون: Pavel M; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; Department of Medicine 1, Friedrich Alexander University Erlangen-Nuernberg, University Hospital Erlangen, Erlangen, Germany., Lahner H; Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany., Hörsch D; Department of Gastroenterology/Endocrinology, Zentralklinik Bad Berka, Bad Berka, Germany., Rinke A; Department of Gastroenterology, University Hospital Gießen and Marburg, Marburg and Philipps University Marburg, Germany., Denecke T; Department of Radiology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Diagnostic and Interventional Radiology, University Medical Center Leipzig, Leipzig, Germany., Koch A; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Regnault B; Ipsen Pharma, Boulogne-Billancourt, France., Helbig D; Ipsen Pharma GmbH, München, Germany., Hoffmanns P; Ipsen Pharma GmbH, München, Germany., Raderer M; Medical University Vienna, Internal Medicine I, Division of Oncology, Vienna, Austria.

المصدر: The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. e643-e654.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Somatostatin*/*analogs & derivatives, Temozolomide*/pharmacology , Temozolomide*/therapeutic use , Temozolomide*/administration & dosage , Somatostatin*/therapeutic use , Somatostatin*/pharmacology , Somatostatin*/administration & dosage , Neuroendocrine Tumors*/drug therapy , Neuroendocrine Tumors*/pathology , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Peptides, Cyclic*/therapeutic use , Peptides, Cyclic*/pharmacology , Peptides, Cyclic*/administration & dosage , Intestinal Neoplasms*/drug therapy , Intestinal Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Aged, 80 and over

المؤلفون: Kiseljak-Vassiliades K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Section of Endocrinology, Department of Medicine, Research Service at Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA., Lipe K; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, Good Samaritan Regional Medical Center, Corvallis, Oregon, USA., Turin CG; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Fishbein L; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Section of Endocrinology, Department of Medicine, Research Service at Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.; Department of Biomedical Informatics, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Costello JC; Department of Pharmacology, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; University of Colorado Cancer Center, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Kerr JM; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Holmstoen TB; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Youssef AS; Department of Neurosurgery, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Lillehei KO; Department of Neurosurgery, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Kleinschmidt-DeMasters BK; Department of Neurosurgery, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Pathology, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Neurology, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Wierman ME; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Section of Endocrinology, Department of Medicine, Research Service at Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.

المصدر: Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2024 Jun 20; Vol. 83 (7), pp. 586-595.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985192R Publication Model: Print Cited Medium: Internet ISSN: 1554-6578 (Electronic) Linking ISSN: 00223069 NLM ISO Abbreviation: J Neuropathol Exp Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Cadherins*/genetics , Cadherins*/biosynthesis , Cadherins*/metabolism , Neuroendocrine Tumors*/genetics , Neuroendocrine Tumors*/pathology , Neuroendocrine Tumors*/metabolism , ACTH-Secreting Pituitary Adenoma*/genetics , ACTH-Secreting Pituitary Adenoma*/pathology , ACTH-Secreting Pituitary Adenoma*/metabolism, Humans ; Female ; Male ; Middle Aged ; Adult ; Retrospective Studies ; Aged ; Transcriptome ; Pituitary Neoplasms/genetics ; Pituitary Neoplasms/pathology ; Pituitary Neoplasms/metabolism ; Young Adult ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic

المؤلفون: Anaka M; Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada.; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Chan D; Northern Sydney Cancer Centre, St Leonards, New South Wales, Australia., Pattison S; Department of Medicine, Otago Medical School, University of Otago, Dunedin, Otago, New Zealand., Thawer A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Franco B; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Moody L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Jackson C; Department of Medicine, Otago Medical School, University of Otago, Dunedin, Otago, New Zealand., Segelov E; Department of Clinical Research, University of Bern, Bern, Switzerland.; Department of Medicine, Monash University, Melbourne, Victoria, Australia., Singh S; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

المصدر: The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. 227-234.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Neuroectodermal Tumors, Primitive* , Neuroendocrine Tumors*/pathology, Humans ; Patient Preference ; Somatostatin/therapeutic use ; Randomized Controlled Trials as Topic

المؤلفون: Morita S; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Uraki S; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Ariyasu H; Department of Diabetes and Endocrinology, Shizuoka General Hospital, Shizuoka 420-8527, Japan., Tsuji T; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Doi A; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Furuta H; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Yamoto T; Department of Neurological Surgery, Wakayama Medical University, Wakayama 641-8509, Japan., Nakao N; Department of Neurological Surgery, Wakayama Medical University, Wakayama 641-8509, Japan., Akamizu T; Department of Internal Medicine, Kuma Hospital, Kobe 650-0011, Japan., Matsuoka TA; First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.

المصدر: Endocrinology [Endocrinology] 2024 Feb 20; Vol. 165 (4).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Internet ISSN: 1945-7170 (Electronic) Linking ISSN: 00137227 NLM ISO Abbreviation: Endocrinology Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/drug therapy , Pituitary Neoplasms*/drug therapy , Pituitary Neoplasms*/genetics , Adenoma* , Benzenesulfonamides* , Naphthalenes*, Humans ; Octreotide ; Endoribonucleases/genetics ; Protein Serine-Threonine Kinases/genetics ; Enzyme Inhibitors ; Unfolded Protein Response ; RNA, Messenger

المؤلفون: Stewart PM; Faculty of Medicine & Health, University of Leeds, Leeds LS2 3AA, UK.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Apr 19; Vol. 109 (5), pp. e1408-e1409.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Pituitary Neoplasms*/diagnosis , Adenoma*/diagnosis , Neuroendocrine Tumors*, Humans ; Pituitary Gland

المؤلفون: Hofland J; ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology, Erasmus MC and Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands., Refardt JC; ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology, Erasmus MC and Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.; ENETS Center of Excellence, Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland., Feelders RA; ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology, Erasmus MC and Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands., Christ E; ENETS Center of Excellence, Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel, CH-4031 Basel, Switzerland., de Herder WW; ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology, Erasmus MC and Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Mar 15; Vol. 109 (4), pp. 1109-1118.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Insulinoma*/diagnosis , Insulinoma*/therapy , Insulinoma*/complications , Pancreatic Neoplasms*/therapy , Pancreatic Neoplasms*/drug therapy , Hypoglycemia*/diagnosis , Hypoglycemia*/etiology , Hypoglycemia*/therapy , Neuroendocrine Tumors*/complications, Humans ; Receptors, Somatostatin/therapeutic use

المؤلفون: Bulzico D; Endocrine Oncology Unit and Nuclear Medicine Section, Brazilian National Cancer Institute, Rio de Janeiro, CEP 20230-130, Brazil.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Feb 20; Vol. 109 (3), pp. e1301-e1302.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/pathology , Multiple Endocrine Neoplasia Type 1*/pathology , Pancreatic Neoplasms*/pathology, Humans ; Proteomics ; Biomarkers

المؤلفون: La Salvia A; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; National Center for Drug Research and Evaluation, National Institute of Health (ISS), 00161 Rome, Italy., Lens-Pardo A; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain., López-López A; Department of Chemistry and Biochemistry, Facultad de Farmacia, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28925 Madrid, Spain., Carretero-Puche C; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain., Capdevila J; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain., Benavent M; Medical Oncology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), 41013 Seville, Spain., Jiménez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, 33011 Oviedo, Spain., Castellano D; Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain., Alonso T; Medical Oncology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., Teule A; Institut Català d'Oncologia (ICO)-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L'Hospitalet del Llobregat, Barcelona, Spain., Custodio A; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC CB16/12/00398, 28046 Madrid, Spain., Tafuto S; Sarcomas and Rare Tumours Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, 80131 Naples, Italy., La Casta A; Department of Medical Oncology, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastián, Spain., Spada F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy., Lopez-Gonzalvez A; Department of Chemistry and Biochemistry, Facultad de Farmacia, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28925 Madrid, Spain., Gil-Calderon B; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain., Espinosa-Olarte P; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain., Barbas C; Department of Chemistry and Biochemistry, Facultad de Farmacia, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28925 Madrid, Spain., Garcia-Carbonero R; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.; Medicine Department, Complutense University of Madrid (UCM), 28040 Madrid, Spain., Soldevilla B; Center of Experimental Oncology, Gastrointestinal and Neuroendrocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.; Genetics, Physiology and Microbiology Department, Complutense University of Madrid (UCM), 28040 Madrid, Spain.

المصدر: European journal of endocrinology [Eur J Endocrinol] 2024 Jan 03; Vol. 190 (1), pp. 62-74.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/pathology , Porphyrins*/therapeutic use, Humans ; Metabolomics ; Methionine/therapeutic use ; Tryptophan ; Case-Control Studies